Advertisement
Research Article| Volume 1, ISSUE 3, P178-185, January 1970

Fibrinogen metabolism following injury and its surgical treatment

  • J.W.L. Davies
    Correspondence
    Requests for reprints should be addressed to:—J.W.L. Davies, Esq., Ph.D., M.R.C. Industrial Injuries and Burns Research Unit, Birmingham Accident Hospital, Bath Row, Birmingham 15, England.
    Affiliations
    M.R.C. Industrial Injuries and Burns Research Unit, Birmingham Accident Hospital, King Gustaf V Research Institute and the Surgical and Medical Departments, Karolinska Sjukhuset, Stockholm, Sweden
    Search for articles by this author
  • S.-O. Liljedahl
    Affiliations
    M.R.C. Industrial Injuries and Burns Research Unit, Birmingham Accident Hospital, King Gustaf V Research Institute and the Surgical and Medical Departments, Karolinska Sjukhuset, Stockholm, Sweden
    Search for articles by this author
  • P. Reizenstein
    Affiliations
    M.R.C. Industrial Injuries and Burns Research Unit, Birmingham Accident Hospital, King Gustaf V Research Institute and the Surgical and Medical Departments, Karolinska Sjukhuset, Stockholm, Sweden
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      Studies with radioactively labelled fibrinogen given to elderly and young injured patients subjected to reparative surgery showed that:—
      • 1.
        The actual amount of labelled protein (mg. per kg.) catabolized per day was increased to between 2 and 3 times normal, in both the young and elderly patients.
      • 2.
        In elderly injured patients more radioactivity was found outside the active circulation than found outside the circulation of young injured patients or in normal persons. This radioactivity outside the circulation had a longer biological half-life than that of the plasma fibrinogen, suggesting that the non-circulating radioactivity was attached to fibrin.
      • 3.
        The rate of synthesis of fibrinogen was increased in both the young and elderly injured patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Injury
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Adelson E.
        • Rheingold J.J.
        • Parker O.
        • Buenaventura A.
        • Crosby W.H.
        Platelet and Fibrinogen Survival in Normal and Abnormal States of Coagulation.
        Blood. 1961; 17: 267
        • Amris A.
        • Amris C.J.
        Turnover and Distribution of 131Iodine labelled Human Fibrinogen.
        Thromb. Diath. haemorrh. 1964; 11: 404
        • Borgström S.
        Postoperative Anticoagulant Prophylaxis of Venous Thrombosis with Dicoumarol.
        Zentbl. Phlebol. 1967; 6: 30
        • Davies J.W.L.
        • Ricketts C.R.
        • Bull J.P.
        Studies of Plasma Protein Metabolism. I. Albumin in Burned and Injured Patients.
        Clin. Sci. 1962; 23: 411
        • Davies J.W.L.
        • Ricketts C.R.
        • Bull J.P.
        Studies of Plasma Protein Metabolism. III. Fibrinogen in Burned Patients.
        Clin. Sci. 1966; 30: 305
        • Eeles G.H.
        • Sevitt S.
        Microthrombosis in Injured and Burned Patients.
        J. Path. Bact. 1967; 93: 275
        • Egeberg O.
        Changes in the Coagulation System following Major Surgical Operations.
        Acta med. scand. 1962; 171: 679
        • Einhorn J.
        • Reizenstein P.
        Metabolic Studies on Folic Acid in Malignancy.
        Cancer Res. 1966; 26: 340
      1. ([in Swedish])
        • Elman Å.
        • Einhorn J.
        • Liljedahl S.-O.
        • Reizenstein P.
        Plasma Elimination of Nutrients (P.E.O.N.) causing Secondary Nutritional Maldistribution Anaemia.
        in: Transactions of the Swedish Physicians National Conference. 1968
        • Flanc C.
        • Kakkar V.V.
        • Clarke M.B.
        Postoperative Deep Vein Thrombosis—Effect of Intensive Prophylaxis.
        Lancet. 1969; 1: 477
        • Gelin L.-E.
        Studies in Anemia of Injury.
        Acta chir. scand. 1956;
        • Godal H.C.
        Quantitative and Qualitative Changes in Fibrinogen following Major Surgical Operations.
        Acta med. scand. 1962; 171: 687
        • Innes D.
        • Sevitt S.
        Coagulation and Fibrinolysis in Injured Patients.
        J. clin. Path. 1964; 17: 1
        • Kaijser L.
        • Rieger Å
        Blood Volume and Plasma Protein. V. Changes in Blood Volume and Plasma Proteins on Administration of Different Substitutes after Operations in Man.
        Acta chir. scand. 1968; 134: 1
        • Kukral J.C.
        • Zeineh R.
        • Dobryszycka W.
        • Pollitt J.
        • Stone N.
        Metabolism of Plasma Proteins in Injury States. I. Turnover Rates of Fibrinogen in Burned Patients labelled with [35S] Methionine.
        Clin. Sci. 1969; 36: 231
        • Leandoer L.
        • Appelgren L.
        • Bergentz S.-E.
        Fibrinogen Turnover after Massive Haemorrhage in Dogs studied with radioactively labelled Fibrinogen.
        Acta chir. scand. 1968; 134: 410
        • Lewis J.H.
        • Ferguson E.E.
        • Schoenfeld C.
        Studies concerning the Turnover of Fibrinogen I131 in the Dog.
        J. Lab. clin. Med. 1961; 58: 247
        • Liljedahl S.-O.
        • Reizenstein P.
        • Åsen P.
        Studies on Trauma. III. Plasma Iron Elimination Rate.
        Acta chir. scand. 1969; 135: 275
        • McFarlane A.S.
        In vivo Behaviour of I131 Fibrinogen.
        J. clin. Invest. 1963; 42: 346
        • McFarlane A.S.
        • Todd D.
        • Cromwell S.
        Fibrinogen Catabolism in Humans.
        Clin. Sci. 1964; 26: 415
        • Prendergast J.J.
        • Fenichel R.L.
        • Daly B.N.
        Albumin and Globulin Changes in Burns as demonstrated by Electrophoresis.
        Archs Surg., Chicago. 1952; 64: 733
        • Regoeczi E.
        The Use of 131Fibrinogen for in Vivo Studies. Labelled Proteins in Tracer Studies.
        Euratom Brussels. 1966; 85 (EUR 2950 d, f, e)
        • Reizenstein P.
        • Karlsson H.Å.
        Clinical Whole Body Counting—Whole Body Scanner with Two Crystals.
        Acta radiol. 1966; 4: 209
      2. (ch. 2)
        • Sevitt S.
        Burns—Pathology and Therapeutic Applications.
        Butterworths, London1957
        • Sevitt S.
        • Gallagher N.G.
        Prevention of Venous Thrombosis and Pulmonary Embolism in Injured Patients.
        Lancet. 1959; 2: 981
        • Takeda Y.
        Studies of the Metabolism and Distribution of Fibrinogen in Healthy Men with Autologous 125I labelled Fibrinogen.
        J. clin. Invest. 1966; 45: 103
        • Warren R.
        • Amdur M.O.
        • Belko J.
        • Baker D.V.
        Postoperative Alterations in the Coagulation Mechanism of the Blood.
        Archs Surg., Chicago. 1950; 61: 419